Swedish Orphan Biovitrum publ AB (SOBIV.ST)
SOBIV.ST on Stockholm Stock Exchange
Price Change (% chg)
Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers... (more)
|Market Cap (Mil.):||kr18,859.69|
|Shares Outstanding (Mil.):||270.39|
Earnings vs. Estimates
Analyst Research Reports
Swedish Orphan Biovitrum AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.